<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B064CE8B-BE00-4DC2-A5FA-A4772A6BA92A"><gtr:id>B064CE8B-BE00-4DC2-A5FA-A4772A6BA92A</gtr:id><gtr:name>UK Regenerative Medicine Platform</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88077807-2572-4B6D-8467-0822C6A212BD"><gtr:id>88077807-2572-4B6D-8467-0822C6A212BD</gtr:id><gtr:name>NHS Blood and Transplant (NHSBT)</gtr:name><gtr:address><gtr:line1>Oak House
Reeds Crescent</gtr:line1><gtr:city>Watford</gtr:city><gtr:postCode>WD24 4QN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CB90AF84-0C45-4AE3-A91A-5F9EDBE89398"><gtr:id>CB90AF84-0C45-4AE3-A91A-5F9EDBE89398</gtr:id><gtr:name>Cell Therapy Catapult</gtr:name><gtr:address><gtr:line1>12th Floor Tower Wing, Guys Hospital, 
Great Maze Pond,</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 9RT</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/445125BE-0D26-4035-9BFE-A99B4F339354"><gtr:id>445125BE-0D26-4035-9BFE-A99B4F339354</gtr:id><gtr:name>UKRMP Acellular Hub and UKRMP Immunomodulation Hub (Delcassian)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Ear Institute</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B064CE8B-BE00-4DC2-A5FA-A4772A6BA92A"><gtr:id>B064CE8B-BE00-4DC2-A5FA-A4772A6BA92A</gtr:id><gtr:name>UK Regenerative Medicine Platform</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88077807-2572-4B6D-8467-0822C6A212BD"><gtr:id>88077807-2572-4B6D-8467-0822C6A212BD</gtr:id><gtr:name>NHS Blood and Transplant (NHSBT)</gtr:name><gtr:address><gtr:line1>Oak House
Reeds Crescent</gtr:line1><gtr:city>Watford</gtr:city><gtr:postCode>WD24 4QN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CB90AF84-0C45-4AE3-A91A-5F9EDBE89398"><gtr:id>CB90AF84-0C45-4AE3-A91A-5F9EDBE89398</gtr:id><gtr:name>Cell Therapy Catapult</gtr:name><gtr:address><gtr:line1>12th Floor Tower Wing, Guys Hospital, 
Great Maze Pond,</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SE1 9RT</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/445125BE-0D26-4035-9BFE-A99B4F339354"><gtr:id>445125BE-0D26-4035-9BFE-A99B4F339354</gtr:id><gtr:name>UKRMP Acellular Hub and UKRMP Immunomodulation Hub (Delcassian)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F681C3BE-A575-4501-8DBF-71748EC25F92"><gtr:id>F681C3BE-A575-4501-8DBF-71748EC25F92</gtr:id><gtr:firstName>Laura</gtr:firstName><gtr:surname>Vallejo-Torres</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B6672D70-4424-4167-AA89-83E246BD56E5"><gtr:id>B6672D70-4424-4167-AA89-83E246BD56E5</gtr:id><gtr:firstName>Anne GM</gtr:firstName><gtr:surname>Schilder</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/31D6FF73-C4C8-4FE1-93A2-E00FA28722DC"><gtr:id>31D6FF73-C4C8-4FE1-93A2-E00FA28722DC</gtr:id><gtr:firstName>Sam</gtr:firstName><gtr:surname>Janes</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E152C9CB-3061-49C5-B610-694F239023CA"><gtr:id>E152C9CB-3061-49C5-B610-694F239023CA</gtr:id><gtr:firstName>Tahera</gtr:firstName><gtr:surname>Ansari</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2D37AC0C-F519-484D-B5D8-E84C5B99B10B"><gtr:id>2D37AC0C-F519-484D-B5D8-E84C5B99B10B</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Lowdell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/710FFB6D-6B60-463F-89CE-976C20E7FFB6"><gtr:id>710FFB6D-6B60-463F-89CE-976C20E7FFB6</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Mason</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/69D76662-7C19-4E02-B68D-6ADB2F2D96C9"><gtr:id>69D76662-7C19-4E02-B68D-6ADB2F2D96C9</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Anthony</gtr:otherNames><gtr:surname>Birchall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DE2374D4-3E7B-4E9C-9904-639CF53E0A8C"><gtr:id>DE2374D4-3E7B-4E9C-9904-639CF53E0A8C</gtr:id><gtr:firstName>Alexander</gtr:firstName><gtr:otherNames>Marcus</gtr:otherNames><gtr:surname>Seifalian</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1D08B535-BC5A-4F26-A58C-8590DB89F62B"><gtr:id>1D08B535-BC5A-4F26-A58C-8590DB89F62B</gtr:id><gtr:firstName>Rose Mary</gtr:firstName><gtr:surname>Sheridan</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/28F7F462-BB62-4596-9FC2-38D7D1DBA4BD"><gtr:id>28F7F462-BB62-4596-9FC2-38D7D1DBA4BD</gtr:id><gtr:firstName>Gareth</gtr:firstName><gtr:surname>Ambler</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0B637EB1-4DC5-4F90-B729-3390CB710F68"><gtr:id>0B637EB1-4DC5-4F90-B729-3390CB710F68</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Hollander</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AA6684EB-58FE-4C43-B6C6-327829C84AAB"><gtr:id>AA6684EB-58FE-4C43-B6C6-327829C84AAB</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:surname>Tebbs</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/DD17CE09-4F7A-4577-A8A3-7F9F9614B96B"><gtr:id>DD17CE09-4F7A-4577-A8A3-7F9F9614B96B</gtr:id><gtr:firstName>Gurpreet</gtr:firstName><gtr:otherNames>Singh</gtr:otherNames><gtr:surname>Sandhu</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK026453%2F1"><gtr:id>6039BD76-9195-433C-894E-4536CF2FCA74</gtr:id><gtr:title>RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K026453/1</gtr:grantReference><gtr:abstractText>The larynx protects the airway during swallowing, regulates breathing, and permits voice: all fundamental human functions. Over 2000 UK patients lose laryngeal function due to trauma or cancer annually and need to spend a lot of time at or in hospitals. 1300 NHS patients a year have their larynx removed entirely. Conventional treatments for these patients leave many with substantial problems talking, swallowing and breathing. For example, the use of combined chemotherapy and radiotherapy for laryngeal cancer results in hoarseness and painful swallowing and can even render the larynx completely disabled. However, if we could accurately replace the normal contours and structure of the larynx, for example by using a living tissue-engineered replacement, the quality of life (and in some cases survival) of these patients would be transformed. In this project we build on some well-publicised successes in replacing the windpipes of adults and children to deliver a laryngeal reconstruction product made from the patient's own stem cells and a laryngeal scaffold prepared, with appropriate permissions, from transplant donors. Our goal is thereby to produce a safe, effective and reasonably therapy suitable for routine NHS use, resulting in improved quality of life for patients and carers. 

The product will be a partial laryngeal replacement construct, composed of a a human donor scaffold from which all donor cells have been chemically stripped. This means that the implant will not get rejected, like normal transplants, and so patients do not need immunosuppressant medication, with all the side effects that would entail. Based on extensive laboratory work, we are able to turn the patient's stem cells into cartilage-producing cells to give natural strength to the product, and also produce a replacement mucous membrane to line the inside, just like a normal larynx. Similar technology worked well for our adult and child windpipe recipients treated for life-saving reasons. To perform this work, we need a further years' preparation for a clinical trial, which will then follow ten implanted patients for two years in order to demonstrate to the regulatory authorities that the product is both safe and effective. This will, in turn, allow us to apply to use the technology routinely in the NHS and to market it to bring in much needed funds to our hospitals. Since this is the first stem-cell based organ replacement to enter clinical trials to our knowledge, this project has far-reaching 'path-finding' implications for other related organ replacements such as those for oesophagus and lung. Even more value will be obtained from this work by developing ways of studying cells and tissues in man in trials like this so that we can learn as much about the underlying science of stem cells and tissue repair as possible. Finally, we will study the detailed economics of moving treatments like this into routine healthcare, and determine the most cost-effective ways this can be managed, as well as making sure that any new inventions bring in as much finance as possible to the UK.</gtr:abstractText><gtr:technicalSummary>There are no satisfactory conventional solutions for patients with end-stage laryngeal stenosis, which can result from trauma or after cancer resection. This has profound impacts on quality of life, especially swallowing, breathing and talking. Based on our 'first-in-human' successes with tracheal implants1,2, we developed an autologous stem cell and biologic scaffold based partial laryngeal implant to correct severe structural disorders. In preclinical studies, this was biocompatible in rats, and safe and effective in pigs (human cells in immunosuppressed animals). We have developed robust processes for production of cells, scaffold, bioreactor and implant within our fully Good Manufacturing Practice (GMP) licensed cell therapy facility. UCLH hosts the national airway service, which has the largest pool of potential recipients in Europe, and skilled clinical staff.
We propose a 50 months' project to encompass a phase I/IIa clinical trial of customized stem cell based laryngeal implants in ten patients with severe laryngeal stenosis who have exhausted conventional therapeutic options, and with two years' follow-up. 
Milestones will be:
1. Obtain necessary authorisations, and perform first implant
2. Complete recruitment and submit processes for IP assessment
3. First two patients attain 6- and 12-month efficacy targets; cost-reduction achieved
4. Completion of follow-up, reporting to MRC and MHRA and publication in high impact journal</gtr:technicalSummary><gtr:potentialImpactText>Who benefits?

2000 UK patients p.a. lose laryngeal function due to trauma or cancer. The main immediate non-academic beneficiaries will be UK patients, their carers and relatives.

In the immediate term, other beneficiaries are both academic and commercial: clinicians, scientists and engineers working in the multidisciplinary environment of regenerative medicine and its robust application to the clinic, life scientists in the field of stem cells and tissue engineering who want to obtain new ways of studying the human organism, and those working at the biotech interface. In the immediate term, benefit will also accrue to the employed researchers, and then the wider UK and international academic communities, public and private education and healthcare sectors, and industry, in which they will be employed. 
In the medium- to long-term, beneficiaries include the wider pool of patients with airway disorders, clinicians, the NHS and industry, and ultimately the international healthcare market and needy patients worldwide. Finally, through public engagement, the UK public will also benefit. Also in the longer-term, and if the technology sees it through to commercialisation, University College, London, our host hospital Trusts and the UK economy will benefit. Persons trained in this programme form an invaluable, multidisciplinary reservoir of human resource to help drive and guide the growing RegenMed industry in the UK. 

How will they benefit?

The research will have a direct impact on UK health and wealth. The health benefits will come from facilitating UK regenerative medicine by developing the next generation of technologies for the 3d Scaffold and cells growth, characterisation, monitoring and tracking stem cells for clinical applications but also by providing the necessary translational skills to enable the research to directly impact upon the clinic. The outputs will be disseminated widely to all the stakeholder. The ultimate benefit of the research will be a step-change in the production of 3D cell-based scaffold including going from the existing 'open systems' with their reliance on the skill of the operator and a very large manual component towards a closed automatable system. Furthermore, success in this single application will substantially de-risk the field of 3-D tissue-engineered product development by other academic groups and commercial partners.

Whilst the research will concentrate on exploring safety and efficacy of laryngeal replacement implants with immediate outputs at clinical and technology levels, the overall benefits will be far wider and will ultimately impact upon patients with a wide range of organ and tissue replacement needs, such as adults and children with oesophageal and bowel disorders (related hollow organs). 

As the research is at the interface between the physical, biological and clinical and management sciences, it offers unique opportunities for training in multidisciplinary research to employed researchers, which will equip them with new skills and give them essential experience for research or related jobs in academia, education, healthcare, and the emerging advanced therapies industry.

What will be done to ensure that they benefit? 

We will deliver our Impact Plan through robust, milestone driven and quality controlled management systems, tested by both application to other trials by our highly experienced trials team, and in first-in-human compassionate patients where we demonstrated proof-of-principle of our technology. 

We will provide high-quality, tailored and mentored, training to the post-doctoral researchers at the interface between the physical, biological and medical sciences. We have a very strong track record in this arena.

We work seamlessly with UCL Business to explore the potential market for a RegenVOX technology and any potential spin-offs. We embed herein a highly important stream to map out pathways to commercialisation of complex ATMPs.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-04-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2856445</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Blood and Transplant (NHSBT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Blood Service</gtr:department><gtr:description>supply of human tissue</gtr:description><gtr:id>3515F75B-A41E-495D-8493-597984B47FC6</gtr:id><gtr:impact>We are about to implant the first clinical trial patient. the collaboration made up of clinicians, surgeons and scientists</gtr:impact><gtr:outcomeId>58c6cef3ab6128.30704825-1</gtr:outcomeId><gtr:partnerContribution>My research team use the human tissue as part of the research programme. Our lab decellularises the organ and re-seeds with patients stem cells to grow an implantable organ</gtr:partnerContribution><gtr:piContribution>NHSBT supply the human tissue which is used in our research programme.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UK Regenerative Medicine Platform</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Novel hydrogels for respiratory epithelial delivery</gtr:description><gtr:id>CD3554D1-C01A-48C5-AB10-0E83A639924F</gtr:id><gtr:impact>Just commenced</gtr:impact><gtr:outcomeId>nyyT7hmfR5D-1</gtr:outcomeId><gtr:partnerContribution>Supply of novel hydrogels and other materials</gtr:partnerContribution><gtr:piContribution>Clinical and scientific need, ability to translate into preclinical and clinical studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cell Therapy Catapult</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>commercialisation of stem cell based airway products</gtr:description><gtr:id>62A0B0A2-96ED-493F-B1C3-3B884C8A07F5</gtr:id><gtr:impact>Successful TSB award for phase I clinical trial</gtr:impact><gtr:outcomeId>qeXFsr6DH8H-1</gtr:outcomeId><gtr:partnerContribution>Clinical trial and commercialisation support costs</gtr:partnerContribution><gtr:piContribution>All academic input and IP</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UKRMP Acellular Hub and UKRMP Immunomodulation Hub (Delcassian)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UK Regenerative Medicine Platform for Acellular Materials external advisor</gtr:description><gtr:id>B0AF0D53-004C-410B-9FE7-76CE86B0AA89</gtr:id><gtr:impact>Application for renewal funding</gtr:impact><gtr:outcomeId>58c5a49e1150e1.00007845-1</gtr:outcomeId><gtr:partnerContribution>Development of a number of novel materials and gels for therapeutic application</gtr:partnerContribution><gtr:piContribution>I am part of the external advisory group, and have specific oversight of clinical translation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>National Foundation of Swallowing Disorders Webinar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7A2A8D70-8F88-4F3F-991A-AF251536C536</gtr:id><gtr:impact>this was an international webinar to discuss swallowing disorders designed to inform patients, carers and medical professionals of the latest treatments and current research associated with dysphagia. It has resulted in further enquiries from patients about the direction of therapies and Prof Birchall has been invited to attend the Dysphagia Surgical Society meeting in San Diego in April 2017.</gtr:impact><gtr:outcomeId>58c8286b7f2a70.78615638</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://swallowingdisorderfoundation.com/new-webinar-building-a-future-that-is-easier-to-swallow/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The One Show, BBC1</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5D8D0C52-F483-4E83-BC9E-F990494D2E40</gtr:id><gtr:impact>This will follow the patient journey of one of our trial patients undergoing laryngeal reinnervation as they go form having a severely damaged voice to one that is near normal</gtr:impact><gtr:outcomeId>58c5a0b17e49b9.97711500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Body of Songs</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>347735CD-FD2E-4358-8622-D763413239EC</gtr:id><gtr:impact>Worked with a musician to record images of his larynx while he was singing. this was part of a larger project involving other musicans/artists and specialist clinicians.</gtr:impact><gtr:outcomeId>56f01d629e7fa4.79140083</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://bodyofsongs.co.uk/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TEDX Warwick talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E984D5BA-EE3E-44E7-B598-FE042FA62B66</gtr:id><gtr:impact>My presentation provoked great interest and many questions followed. I have since been in touch with fellow presenters with potential for possible projects related to the voice.

The audience was very receptive to my talk and I have been contacted since then to do more presentations and attend more events.</gtr:impact><gtr:outcomeId>5464c0fe4943f8.26828101</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival regenerative medicine showcase</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70F67C12-C528-42EE-BED2-C86F5A0224B5</gtr:id><gtr:impact>100 paying public participants; &amp;gt;400,000 hits for on-line webcast

Invited to develop further for Brighton Science Festival and Warwick TED-X talk, March, 2014; invited to speak to a variety of secondary school audiences nationally.</gtr:impact><gtr:outcomeId>D58fJiJuSwE</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brighton Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>4820FEF0-7BED-47A5-A8B6-B5C06559D31F</gtr:id><gtr:impact>The audience showed great enthusiasm after the talk, asking questions and asking for further information.

Some young people who attended the festival were in touch following the talk, interested in coming to see my work.</gtr:impact><gtr:outcomeId>5464bec39ba019.72030672</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK SCF Open Call</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>UK Stem Cell Foundation</gtr:fundingOrg><gtr:id>A26C676D-A5D3-4DAF-9FBC-B71DB29427F7</gtr:id><gtr:outcomeId>b1iTu1hK2JF</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>280000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Training Fellowship</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>58283939-36A7-4CF8-A9E1-AD8ABC12FC8B</gtr:id><gtr:outcomeId>58c7d8b1efb374.61069660</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Studentship project</gtr:description><gtr:end>2019-06-02</gtr:end><gtr:fundingOrg>Rosetrees Trust</gtr:fundingOrg><gtr:fundingRef>174353</gtr:fundingRef><gtr:id>94F3AEA2-1751-4ABA-A216-C45E29CB989A</gtr:id><gtr:outcomeId>58c822febc2a15.01202627</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>280000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Bloomsbury Centre</gtr:department><gtr:description>Training Fellowship</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4546A353-9B53-467E-90BA-70BB6F36DBE2</gtr:id><gtr:outcomeId>58c7d64c3245f7.71918529</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Technology Strategy Board Regenerative Medicine Call</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>00297BC0-2920-4E2D-948F-448AC3355D8F</gtr:id><gtr:outcomeId>knEyhhmFLur</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fellowship (Jasmine Ho)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N002113/1</gtr:fundingRef><gtr:id>1A21F043-4D00-4933-B265-B6E69456D1BF</gtr:id><gtr:outcomeId>58c82399b7d091.32675083</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>455118</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>TETRA H20:20</gtr:description><gtr:end>2020-01-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>681027</gtr:fundingRef><gtr:id>DACF1DF3-FC62-487D-95D9-90F25E34CCB0</gtr:id><gtr:outcomeId>56f01a832b1376.40271007</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>260000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical Research Training Fellowship (N. Hamilton)</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>10F187B4-642B-40DF-BD52-264229605A9E</gtr:id><gtr:outcomeId>qieNmyoG32y</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisor to house of Commons Select Committee on Regenerative Medicine, October 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C801F1F5-D13D-4AE4-88C1-BD960BBFC079</gtr:id><gtr:outcomeId>58c5a6d1364755.51797509</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>One of only four regenerative medicine technologies highlighted in '8 Great Technologies' by DTI</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>1AD29476-4E4F-46C6-BABE-035BDA546169</gtr:id><gtr:impact>Resulted in further citation as exemplar by MHRA for improvements in ATMP regulations at EME.</gtr:impact><gtr:outcomeId>iYM5ZnyQgq8</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>MRC funded phase I/II clinical trial</gtr:description><gtr:id>20D9A558-B2DA-457C-A7FB-A81A745F02DF</gtr:id><gtr:impact>First ever clinical trial of a stem cell based organ replacement</gtr:impact><gtr:outcomeId>qogsDG7N7rM</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>Stem cell based tissue engineered laryngeal implant</gtr:title><gtr:type>Therapeutic Intervention - Surgery</gtr:type><gtr:url>http://clinicaltrials.gov/show/NCT01977911</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Serum and animal-derived feeder layer-free epithelial sheets for use clinically or as a screening tool for therapeutics and animal replacement.</gtr:description><gtr:id>95DF693E-7E1A-47B4-9223-B7D0092EFBB9</gtr:id><gtr:impact>Rapid regeneration of laryngeal mucosa after injury; basis for a CASE studentship for near-human 3D laryngeal model</gtr:impact><gtr:outcomeId>58c59aee5f7e89.91790520</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tissue engineered laryngeal mucosal sheet</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Bioreactor for preparation and transport of tissue engineered laryngeal implants</gtr:description><gtr:id>C9D4FCCC-C004-4F66-BA0C-545201AAE8B0</gtr:id><gtr:impact>Improved speed, efficiency and sterility of implant preparation and transport</gtr:impact><gtr:outcomeId>58c59a6f76af55.87288742</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Laryngeal bioreactor</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5BAE261C-C06D-45A7-86F7-AEF94797EA46</gtr:id><gtr:title>Towards reconstruction of epithelialized cartilages from autologous adipose tissue-derived stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65052f3b0ac7077e2f47e8445253c0c9"><gtr:id>65052f3b0ac7077e2f47e8445253c0c9</gtr:id><gtr:otherNames>New SEP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>58c6d249be5b65.68242329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FF7DFFB-C2D5-4E94-8167-1935EB33DF2A</gtr:id><gtr:title>A Biodesigned Nanocomposite Biomaterial for Auricular Cartilage Reconstruction.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ac111507d1dd29e0aa46074a575bd61"><gtr:id>7ac111507d1dd29e0aa46074a575bd61</gtr:id><gtr:otherNames>Nayyer L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>58c6d24a1d73a7.02522439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C081D361-BCBA-4365-9C83-B0FD5F1D4C49</gtr:id><gtr:title>A potential platform for developing 3D tubular scaffolds for paediatric organ development.</gtr:title><gtr:parentPublicationTitle>Journal of materials science. Materials in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0844eb69e5cb41b31901f020e53e96d"><gtr:id>e0844eb69e5cb41b31901f020e53e96d</gtr:id><gtr:otherNames>de Mel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0957-4530</gtr:issn><gtr:outcomeId>56f00d4b136c20.17358375</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88055DAD-70F9-49C7-9705-A7ABB7186B0B</gtr:id><gtr:title>Innate Immune Response of the Pig Laryngeal Mucosa to Endotracheal Intubation.</gtr:title><gtr:parentPublicationTitle>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f40fb71f898cc01bb26489b037a39d63"><gtr:id>f40fb71f898cc01bb26489b037a39d63</gtr:id><gtr:otherNames>Hughes OR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0194-5998</gtr:issn><gtr:outcomeId>56f00c82183d63.40390940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1202AF29-9338-40A6-88E0-ACFCD48B8E5F</gtr:id><gtr:title>Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patients.</gtr:title><gtr:parentPublicationTitle>Modern rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-7595</gtr:issn><gtr:outcomeId>54648be81eb548.11630707</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F39B930F-8F4C-4181-9072-70CD79030561</gtr:id><gtr:title>Tissue banking in ENT: challenges and methods.</gtr:title><gtr:parentPublicationTitle>The Journal of laryngology and otology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6fcc38349b5e546acdfd7e05e5bbb28b"><gtr:id>6fcc38349b5e546acdfd7e05e5bbb28b</gtr:id><gtr:otherNames>Warner E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2151</gtr:issn><gtr:outcomeId>pm_14813_23_23790140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC76E3D-95AB-4CD5-BD7C-4DFDAF33D9DC</gtr:id><gtr:title>Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94fbab1120fb5702c096ea5859613a98"><gtr:id>94fbab1120fb5702c096ea5859613a98</gtr:id><gtr:otherNames>Hachani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>56f00d4a4ae219.63866964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9857723B-E629-41FC-96AB-06C7FEC53872</gtr:id><gtr:title>Development of resorbable nanocomposite tracheal and bronchial scaffolds for paediatric applications.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/946036cee1562764b824a28a929c892b"><gtr:id>946036cee1562764b824a28a929c892b</gtr:id><gtr:otherNames>Teoh GZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn><gtr:outcomeId>56f00d841d6c86.80606787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67D82DA1-E433-46FF-B075-18D72D410071</gtr:id><gtr:title>Trachea transplantation: from laboratory to patient</gtr:title><gtr:parentPublicationTitle>Journal of Tissue Engineering and Regenerative Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e95e5d3f15eb416693a81c9c254562d3"><gtr:id>e95e5d3f15eb416693a81c9c254562d3</gtr:id><gtr:otherNames>Crowley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>54648c61144bf9.05811959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29C476BD-61C8-44AC-AB42-AB8BEE7F09D8</gtr:id><gtr:title>Tissue engineering airway mucosa: a systematic review.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9bd1e04a0e8b829468f77b62ba6f952"><gtr:id>a9bd1e04a0e8b829468f77b62ba6f952</gtr:id><gtr:otherNames>Hamilton N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>pm_14813_23_24129819</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C0AA865-6C08-45D1-BEB4-0FE873CA3848</gtr:id><gtr:title>The body as a living bioreactor: a feasibility study of pedicle flaps for tracheal transplantation.</gtr:title><gtr:parentPublicationTitle>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21981a18bf473e24e25013a04672ee7c"><gtr:id>21981a18bf473e24e25013a04672ee7c</gtr:id><gtr:otherNames>Jana T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0937-4477</gtr:issn><gtr:outcomeId>pm_14813_23_22829157</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BC478B9-EF11-489A-949B-017FBA878764</gtr:id><gtr:title>Design and development of nanocomposite scaffolds for auricular reconstruction.</gtr:title><gtr:parentPublicationTitle>Nanomedicine : nanotechnology, biology, and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ac111507d1dd29e0aa46074a575bd61"><gtr:id>7ac111507d1dd29e0aa46074a575bd61</gtr:id><gtr:otherNames>Nayyer L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-9634</gtr:issn><gtr:outcomeId>pm_14813_23_23792331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C9280E5-0978-4B93-AD70-1D112BD8DDBE</gtr:id><gtr:title>Correction: Polyol synthesis, functionalisation, and biocompatibility studies of superparamagnetic iron oxide nanoparticles as potential MRI contrast agents.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94fbab1120fb5702c096ea5859613a98"><gtr:id>94fbab1120fb5702c096ea5859613a98</gtr:id><gtr:otherNames>Hachani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>58c6d4380988e6.05541985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>527CAE2F-ACBC-4A3B-9159-11486D05E4E4</gtr:id><gtr:title>Characterization of a biologically derived rabbit tracheal scaffold.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical materials research. Part B, Applied biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7e875c741084b1cc15afd65eec384ea"><gtr:id>c7e875c741084b1cc15afd65eec384ea</gtr:id><gtr:otherNames>Lange P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4973</gtr:issn><gtr:outcomeId>58c6ccbb0b02a2.50564730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD0DE15E-DD5A-468C-91C7-B67E6FA2D09F</gtr:id><gtr:title>Feasibility of vocal fold abduction and adduction assessment using cine-MRI.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69c5d871257df60500b35b893cec55e6"><gtr:id>69c5d871257df60500b35b893cec55e6</gtr:id><gtr:otherNames>Baki MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn><gtr:outcomeId>58c6d00aaef7b1.41970399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071F2187-779A-4AB6-9763-400B028B4ED5</gtr:id><gtr:title>A comparison of tracheal scaffold strategies for pediatric transplantation in a rabbit model.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21078f046c0b2ba7141f2f7af8cbd0b7"><gtr:id>21078f046c0b2ba7141f2f7af8cbd0b7</gtr:id><gtr:otherNames>Maughan EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>5aaa754a0907c9.15642767</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53C348E9-BB00-48E3-94FA-4D243006A5D1</gtr:id><gtr:title>Laryngological presentations of Ehlers-Danlos syndrome: case series of nine patients from two London tertiary referral centres.</gtr:title><gtr:parentPublicationTitle>Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa6d8d91e7cf4b68c4b8aaefa44d7d8d"><gtr:id>aa6d8d91e7cf4b68c4b8aaefa44d7d8d</gtr:id><gtr:otherNames>Arulanandam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1749-4478</gtr:issn><gtr:outcomeId>58c6d249ea4fa4.72345302</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFB7E662-B8F1-40E8-B353-7FCA5E4933FC</gtr:id><gtr:title>Optimized isolation and expansion of human airway epithelial basal cells from endobronchial biopsy samples.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f39e7f67c15e7fa63377e45e027fc19a"><gtr:id>f39e7f67c15e7fa63377e45e027fc19a</gtr:id><gtr:otherNames>Gowers KHC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>5a2fd3466046c0.06671881</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6F7737D-601A-491F-B42D-AA86A3E067CE</gtr:id><gtr:title>Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ceb90299905b4f463ffae257596ad2"><gtr:id>44ceb90299905b4f463ffae257596ad2</gtr:id><gtr:otherNames>Culme-Seymour EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1937-3341</gtr:issn><gtr:outcomeId>56f00d4a1b3e27.75854978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3905013D-4287-4C9E-B649-F9EECD5EA8F3</gtr:id><gtr:title>Laryngotracheal transplantation: technical modifications and functional outcomes.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af211e1ed20ecf1c733525296c92de8c"><gtr:id>af211e1ed20ecf1c733525296c92de8c</gtr:id><gtr:otherNames>Farwell DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>pm_14813_23_23483551</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>851C9572-69BE-4312-8A51-5FE579ACBC09</gtr:id><gtr:title>Stem cell approaches for vocal fold regeneration.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>56f00c81b4afe8.14201798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16FF93F8-A1F9-492F-A2EA-34464A590E44</gtr:id><gtr:title>Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>5675dd1f6e86f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>177193E2-14FB-4C27-8BB1-D96F14513E74</gtr:id><gtr:title>The Host Immune Response to Tissue-Engineered Organs: Current Problems and Future Directions.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/acbf829c2329a51f3f263517c917ee6f"><gtr:id>acbf829c2329a51f3f263517c917ee6f</gtr:id><gtr:otherNames>Wiles K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>56f00c81e3d0b5.92249202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA2FA12F-8A92-4F41-B73D-CA929E86513F</gtr:id><gtr:title>Assessing cellular response to functionalized a-helical peptide hydrogels.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f294aca8c4b19b7b72508dcf908628"><gtr:id>d4f294aca8c4b19b7b72508dcf908628</gtr:id><gtr:otherNames>Mehrban N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>54648f0e72b138.30478929</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE7E6700-3F5B-4BCF-A9E9-889372B1A8AB</gtr:id><gtr:title>OP-1 ARTIFICIAL OESOPHAGUS ENGINEERING IN A 3D DYNAMIC CULTURE.</gtr:title><gtr:parentPublicationTitle>Journal of pediatric gastroenterology and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/825537c6f88f6cdc0dae7390c0f5278f"><gtr:id>825537c6f88f6cdc0dae7390c0f5278f</gtr:id><gtr:otherNames>Camilli C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-2116</gtr:issn><gtr:outcomeId>56f00d4a77f0d9.21295980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C53BCEA6-DEA4-4E1F-A39C-320B7DF413D1</gtr:id><gtr:title>Skeletal muscle tissue engineering: which cell to use?</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>pm_14813_23_23679017</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CDC1074-AFAF-4594-91FD-DFB751B05544</gtr:id><gtr:title>Preservation of micro-architecture and angiogenic potential in a pulmonary acellular matrix obtained using intermittent intra-tracheal flow of detergent enzymatic treatment.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf0894500212f4c124c9835ae038c1dc"><gtr:id>bf0894500212f4c124c9835ae038c1dc</gtr:id><gtr:otherNames>Maghsoudlou P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>pm_14813_23_23727263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23AC7FCE-BE9B-40C2-957E-6B7C9DCBB241</gtr:id><gtr:title>Tissue-Engineered Tracheal Replacement in a Child: A 4-Year Follow-Up Study.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1001a1756e9879385c0c472870e57cc9"><gtr:id>1001a1756e9879385c0c472870e57cc9</gtr:id><gtr:otherNames>Hamilton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>56f00d4ac5efe8.54554282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88DCB4D3-99DF-4EBA-8C52-A6A083289588</gtr:id><gtr:title>Reliability of OperaVOX against Multidimensional Voice Program (MDVP).</gtr:title><gtr:parentPublicationTitle>Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology &amp; Cervico-Facial Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a635125765892a1d6b670fcb08b2979"><gtr:id>0a635125765892a1d6b670fcb08b2979</gtr:id><gtr:otherNames>Mat Baki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1749-4478</gtr:issn><gtr:outcomeId>546492587d2771.63639936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA945C45-8584-4817-A79C-1DBA6EBF758C</gtr:id><gtr:title>Airway tissue engineering: an update.</gtr:title><gtr:parentPublicationTitle>Expert opinion on biological therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2598</gtr:issn><gtr:outcomeId>5464900527a601.30192336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8619B823-A101-415A-AE00-3D22971BC2FF</gtr:id><gtr:title>Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e95e5d3f15eb416693a81c9c254562d3"><gtr:id>e95e5d3f15eb416693a81c9c254562d3</gtr:id><gtr:otherNames>Crowley C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>56f00c1389f328.61854490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDDEB7D1-F567-4DBA-82E8-E0BE3D9D9A8D</gtr:id><gtr:title>Vacuum-assisted decellularization: an accelerated protocol to generate tissue-engineered human tracheal scaffolds.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c1fddf129689a9fb04a4de77a4a411"><gtr:id>08c1fddf129689a9fb04a4de77a4a411</gtr:id><gtr:otherNames>Butler CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>58c6ccbad28b19.78192786</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCB96273-84BE-44F7-871D-40BF91C28CCF</gtr:id><gtr:title>Stem cell-based organ replacements-airway and lung tissue engineering.</gtr:title><gtr:parentPublicationTitle>Seminars in pediatric surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1055-8586</gtr:issn><gtr:outcomeId>54648fc4953178.88334559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5442C020-C263-40FA-923E-949EC350B27E</gtr:id><gtr:title>Novel approach to in-vivo oesophageal regeneration.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6f8b69006af953e9b34fb6d1e46c98b"><gtr:id>c6f8b69006af953e9b34fb6d1e46c98b</gtr:id><gtr:otherNames>Birchall M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58c6ccbb2c4f25.94563977</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E44C7A43-BB54-4347-89DF-AD8D6D5F1A5E</gtr:id><gtr:title>Stem-cell-based, tissue-engineered tracheal replacement in a child - Authors' reply.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5f8dae2024e22c08076119c90ca4a62"><gtr:id>a5f8dae2024e22c08076119c90ca4a62</gtr:id><gtr:otherNames>Birchall MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_14813_23_23312749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>572E8B39-C5F7-4F09-978D-B3CB5F6792FC</gtr:id><gtr:title>Autologous Cell Seeding in Tracheal Tissue Engineering.</gtr:title><gtr:parentPublicationTitle>Current stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21078f046c0b2ba7141f2f7af8cbd0b7"><gtr:id>21078f046c0b2ba7141f2f7af8cbd0b7</gtr:id><gtr:otherNames>Maughan EF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa7506bed3c9.36306665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A532D3C2-6949-4221-B02C-48A7EB331824</gtr:id><gtr:title>Stem Cell-Based Tissue-Engineered Laryngeal Replacement</gtr:title><gtr:parentPublicationTitle>STEM CELLS Translational Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aafc02a9e037435385e9cf2bd5cb59f3"><gtr:id>aafc02a9e037435385e9cf2bd5cb59f3</gtr:id><gtr:otherNames>Ansari T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>58c6c4dd1082c3.58359586</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AA6BDEE-7F48-488C-BE2C-692F9F00C855</gtr:id><gtr:title>Correlation between Reflux and multichannel intraluminal impedance pH monitoring in untreated volunteers.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d30d64f815eee7411d5670bf60cd93d"><gtr:id>0d30d64f815eee7411d5670bf60cd93d</gtr:id><gtr:otherNames>Jett? ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>54648f901d1200.48381477</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4876D8F2-B94F-4F31-8D26-D92B39235884</gtr:id><gtr:title>Pilot study of a novel vacuum-assisted method for decellularization of tracheae for clinical tissue engineering applications.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering and regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7e875c741084b1cc15afd65eec384ea"><gtr:id>c7e875c741084b1cc15afd65eec384ea</gtr:id><gtr:otherNames>Lange P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6254</gtr:issn><gtr:outcomeId>56f00d83e67673.47958288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F82FD2FB-66D8-451E-8DE3-6F157734EB04</gtr:id><gtr:title>Assessment of tissue viability with blood flow measurements.</gtr:title><gtr:parentPublicationTitle>Angiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0844eb69e5cb41b31901f020e53e96d"><gtr:id>e0844eb69e5cb41b31901f020e53e96d</gtr:id><gtr:otherNames>de Mel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-3197</gtr:issn><gtr:outcomeId>pm_14813_23_23913303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E40DAFC5-F13B-44B1-B5E1-27293A334BEA</gtr:id><gtr:title>Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c1fddf129689a9fb04a4de77a4a411"><gtr:id>08c1fddf129689a9fb04a4de77a4a411</gtr:id><gtr:otherNames>Butler CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>56f00c13560963.49487400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9507BABB-72EF-4B39-BDE4-74658E878521</gtr:id><gtr:title>3D bioprinting for tissue engineering: Stem cells in hydrogels</gtr:title><gtr:parentPublicationTitle>International Journal of Bioprinting</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4f294aca8c4b19b7b72508dcf908628"><gtr:id>d4f294aca8c4b19b7b72508dcf908628</gtr:id><gtr:otherNames>Mehrban N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2424-8002</gtr:issn><gtr:outcomeId>5a351ba173da35.46873346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>175162F0-C3E5-4EDD-B7EB-3D08434CE162</gtr:id><gtr:title>Fumed silica nanoparticle mediated biomimicry for optimal cell-material interactions for artificial organ development.</gtr:title><gtr:parentPublicationTitle>Macromolecular bioscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0844eb69e5cb41b31901f020e53e96d"><gtr:id>e0844eb69e5cb41b31901f020e53e96d</gtr:id><gtr:otherNames>de Mel A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1616-5187</gtr:issn><gtr:outcomeId>54648c23d3ce77.37569695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF619378-AB2F-4EC0-96C1-0802A8B2A14C</gtr:id><gtr:title>Tissue engineering's green shoots of disruptive innovation.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5f8dae2024e22c08076119c90ca4a62"><gtr:id>a5f8dae2024e22c08076119c90ca4a62</gtr:id><gtr:otherNames>Birchall MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54648f43f185a8.62125236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>034715B5-7EFB-46C6-87ED-14BD0A235860</gtr:id><gtr:title>The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer.</gtr:title><gtr:parentPublicationTitle>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5e914029aba5da03395a498cd4a9dcd"><gtr:id>c5e914029aba5da03395a498cd4a9dcd</gtr:id><gtr:otherNames>Hamilton DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0937-4477</gtr:issn><gtr:outcomeId>pm_14813_23_23334205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DC55E59-1AFD-44EA-9A0D-6D8F10B9B52C</gtr:id><gtr:title>Reply to: &amp;quot;Recent Advances in Circumferential Tracheal Replacement and Transplantation&amp;quot;.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1001a1756e9879385c0c472870e57cc9"><gtr:id>1001a1756e9879385c0c472870e57cc9</gtr:id><gtr:otherNames>Hamilton NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>58c6ccbb535bc4.69106711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C08A6F74-FB3D-431E-A19E-E0689EF78586</gtr:id><gtr:title>Patient perception of a randomised, controlled trial of laryngeal reinnervation versus thyroplasty for unilateral vocal fold paralysis.</gtr:title><gtr:parentPublicationTitle>The Journal of laryngology and otology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a635125765892a1d6b670fcb08b2979"><gtr:id>0a635125765892a1d6b670fcb08b2979</gtr:id><gtr:otherNames>Mat Baki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2151</gtr:issn><gtr:outcomeId>56f00d4a9e1f84.69221597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D65329EF-B6CA-4539-A58C-8E4099412359</gtr:id><gtr:title>The current status of human laryngeal transplantation in 2017: A state of the field review.</gtr:title><gtr:parentPublicationTitle>The Laryngoscope</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42e1292108974fba735bfed208e83262"><gtr:id>42e1292108974fba735bfed208e83262</gtr:id><gtr:otherNames>Krishnan G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0023-852X</gtr:issn><gtr:outcomeId>58c6d00b161b04.36481804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C7611E1-D52C-46B7-82A0-57BDA72FB058</gtr:id><gtr:title>Expanded population of CD1d-restricted Va24+ cells in a patient with active rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>Clinical immunology (Orlando, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1521-6616</gtr:issn><gtr:outcomeId>54648ecb2a7416.94406336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E24EE998-00A5-429F-A77B-FB140697CDA1</gtr:id><gtr:title>Lancet Commission: Stem cells and regenerative medicine.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ecb862fe535d75b36be733c8b48c8a3"><gtr:id>3ecb862fe535d75b36be733c8b48c8a3</gtr:id><gtr:otherNames>Cossu G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5aaa749de2ff49.19845573</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D6FFC30-0012-4108-8AC5-6F75F6476E97</gtr:id><gtr:title>Tracking stem cells in tissue-engineered organs using magnetic nanoparticles.</gtr:title><gtr:parentPublicationTitle>Nanoscale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94fbab1120fb5702c096ea5859613a98"><gtr:id>94fbab1120fb5702c096ea5859613a98</gtr:id><gtr:otherNames>Hachani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2040-3364</gtr:issn><gtr:outcomeId>pm_14813_23_24108444</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4666CDE6-C028-4169-A6DA-A4AB7E363862</gtr:id><gtr:title>A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies.</gtr:title><gtr:parentPublicationTitle>Journal of tissue engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16285c6f1f1ddc2a7d48489c1a6f4c8f"><gtr:id>16285c6f1f1ddc2a7d48489c1a6f4c8f</gtr:id><gtr:otherNames>Davies BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-7314</gtr:issn><gtr:outcomeId>5aaa74e0bfee27.78115870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A519556-EF20-4A5B-8DC2-9663A6D8784B</gtr:id><gtr:title>Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74bce7dcbee08189ce39ee8b28c8fa83"><gtr:id>74bce7dcbee08189ce39ee8b28c8fa83</gtr:id><gtr:otherNames>Fishman JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_540e176e176218390</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K026453/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>0CDFB83C-594C-4860-B0BE-C82CA4D45B6B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>